TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$50.39
−0.36%0
Insider buys (3m)
49
Insider sells (3m)
-$80.1M
Net value (3m)
-8.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 19, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 78,400 | $55 |
| Oct 19, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 37,270 | $54 |
| Oct 19, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 128,065 | $53 |
| Oct 19, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 200,000 | $8.93 |
| Oct 19, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 43,735 | $27 |
| Sep 17, 2026 | ROTE WILLIAM E. · officer: Chief Research Officer | M-Exempt | 55,000 | $15 |
| Sep 17, 2026 | Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICER | Sale | 79,113 | $64 |
| Sep 17, 2026 | Calvin Sandra · officer: SVP, CHIEF ACCOUNTING OFFICER | Sale | 300 | $64 |
| Sep 17, 2026 | Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICER | M-Exempt | 8,282 | $22 |
| Sep 17, 2026 | ROTE WILLIAM E. · officer: Chief Research Officer | Sale | 270 | $65 |
| Sep 17, 2026 | REED ELIZABETH E · officer: Chief Legal Officer and GC | Sale | 13,874 | $63 |
| Sep 17, 2026 | Cline Christopher R. · officer: CHIEF FINANCIAL OFFICER | Sale | 1,900 | $64 |
| Sep 17, 2026 | Cline Christopher R. · officer: CHIEF FINANCIAL OFFICER | Sale | 27,473 | $62 |
| Sep 17, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 195,841 | $23 |
| Sep 17, 2026 | Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICER | Sale | 8,282 | $65 |
| Sep 17, 2026 | REED ELIZABETH E · officer: Chief Legal Officer and GC | M-Exempt | 37,500 | $15 |
| Sep 17, 2026 | Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICER | M-Exempt | 1,381 | $22 |
| Sep 17, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 96,125 | $64 |
| Sep 17, 2026 | ROTE WILLIAM E. · officer: Chief Research Officer | Sale | 47,746 | $64 |
| Sep 17, 2026 | Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICER | Sale | 1,431 | $65 |
| Sep 17, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 101,691 | $65 |
| Sep 17, 2026 | Calvin Sandra · officer: SVP, CHIEF ACCOUNTING OFFICER | Sale | 800 | $63 |
| Sep 17, 2026 | ROTE WILLIAM E. · officer: Chief Research Officer | Sale | 63,907 | $62 |
| Sep 17, 2026 | Heerma Peter · officer: EVP, CHIEF COMMERCIAL OFFICER | M-Exempt | 100,000 | $11 |
| Sep 17, 2026 | ROTE WILLIAM E. · officer: Chief Research Officer | Sale | 3,000 | $64 |
| Sep 17, 2026 | ROTE WILLIAM E. · officer: Chief Research Officer | M-Exempt | 39,650 | $18 |
| Sep 17, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 270 | $65 |
| Sep 17, 2026 | Dube Eric M · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 95,666 | $23 |
| Sep 17, 2026 | Calvin Sandra · officer: SVP, CHIEF ACCOUNTING OFFICER | Sale | 4,275 | $62 |
| Sep 17, 2026 | ROTE WILLIAM E. · officer: Chief Research Officer | M-Exempt | 57,500 | $27 |
Institutional positioning
13F filings over the trailing two quarters
New 144Increased 222Reduced 179Sold out 29
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Increased | 11,419,586 | May 18, 2026 |
| Jupiter Topco LLC | New Position | 11,324,191 | Aug 14, 2026 |
| FMR LLC | Increased | 10,967,967 | May 15, 2026 |
| BlackRock, Inc. | Increased | 8,020,663 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 7,792,033 | May 13, 2026 |
| FMR LLC | Reduced | 7,096,614 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 4,959,988 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 4,897,417 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 4,568,341 | Aug 14, 2026 |
| STATE STREET CORP | Reduced | 4,256,224 | Sep 22, 2026 |
| PERCEPTIVE ADVISORS LLC | Reduced | 4,142,551 | May 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,108,694 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,045,812 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Reduced | 3,752,574 | Aug 14, 2026 |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | Reduced | 3,270,513 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 19, 2026